𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Recombinant FVIIa in the treatment of bleeding in acquired hemophilia

✍ Scribed by Viviane GuÉrin; ISABELLE CHOSSAT; Hervè DUTRONC; Marc Dubreuil; François Valentin

Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
250 KB
Volume
70
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunoadsorption with single-use columns
Immunoadsorption with single-use columns for the management of bleeding in acquired hemophilia A: A series of nine cases
✍ Martin Brzoska; Manuela Krause; Helmut Geiger; Christoph Betz 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

## Abstract ## Background: Acquired hemophilia A in a setting of bleeding or required surgery frequently places patients into a state of critical illness with high mortality. In this context immunoadsorption (IA) can be used to eliminate coagulation inhibitors quickly to employ recombinant coagula

The use of continuous infusion of factor
The use of continuous infusion of factor concentrates in the treatment of hemophilia
✍ Dr Robert D. Bona; Ralph A. Weinstein; Steven J. Weisman; Ann Bartolomeo; Freder 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 458 KB

Bolus infusion of clotting factor concentrates remains the most common approach to the treatment or prevention of bleeding in patients with hemophilia. Although successful use of continuous infusion of such concentrates has been reported by several groups, this alternative treatment method has not a